873078-93-4 Usage
General Description
N,N-Dimethyl-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethanamine is a chemical compound with the molecular formula C16H27BO3N. It is a borate ester derivative and is commonly used in organic synthesis and as a reagent in chemical reactions. This chemical is a clear, colorless liquid at room temperature and is soluble in both water and organic solvents. It is known for its ability to form stable complexes with other organic compounds and is widely used in the pharmaceutical and agrochemical industries. Additionally, it is also used as a cross-linking agent in the production of polymers and as a stabilizer in the formulation of coatings and adhesives.
Check Digit Verification of cas no
The CAS Registry Mumber 873078-93-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,3,0,7 and 8 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 873078-93:
(8*8)+(7*7)+(6*3)+(5*0)+(4*7)+(3*8)+(2*9)+(1*3)=204
204 % 10 = 4
So 873078-93-4 is a valid CAS Registry Number.
873078-93-4Relevant articles and documents
PYRROLO [2, 3-B] PYRIDINES OR PYRROLO [2, 3-B] PYRAZINES AS HPK1 INHIBITOR AND THE USE THEREOF
-
Paragraph 0401; 0874-0876, (2020/01/08)
Disclosed herein is a compound of Formula (AIII) or (III), or a stereoisomer thereof, or a pharmaceutically acceptable salt thereof, and pharmaceutical compositions comprising thereof. Also disclosed is a method of treating HPK1 related disorders or diseases by using the compound disclosed herein.
PYRAZOLOPYRIMIDIN-2-YL DERIVATIVES AS JAK INHIBITORS
-
Page/Page column 91; 92, (2015/06/25)
New pyrazolopyridmiin-2-yl derivatives are disclosed; as well as process for their preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of Janus Kinases (JAK).
SUBSTITUTED PYRIDOPYRAZINES AS NOVEL SYK INHIBITORS
-
Page/Page column 34, (2013/02/27)
Provided are certain pyridopyrazine compounds, pharmaceutical compositions thereof and methods of use therefor.